» Articles » PMID: 21925897

Autoantibody Formation in Human and Rat Studies of Chronic Rejection and Primary Graft Dysfunction

Overview
Journal Semin Immunol
Date 2011 Sep 20
PMID 21925897
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Lung transplantation is considered a definitive treatment for many lung diseases. However, rejection and other pathologic entities are major causes of morbidity and mortality for lung transplant recipients. Primary graft dysfunction (PGD) and obliterative bronchiolitis (OB) are the leading causes of early and late mortality, respectively. While the immune basis of PGD has not been clearly defined, evidence is emerging about roles for autoantibodies in this process. Similarly, the pathogenesis of OB has been linked recently to autoimmunity. This review will highlight the current understanding of autoantibodies in PGD and OB post lung transplantation.

Citing Articles

Cellular and molecular mechanisms of cell damage and cell death in ischemia-reperfusion injury in organ transplantation.

Dugbartey G Mol Biol Rep. 2024; 51(1):473.

PMID: 38553658 PMC: 10980643. DOI: 10.1007/s11033-024-09261-7.


Antibody-Mediated Rejection: Diagnosis and Treatment.

Halverson L, Hachem R Clin Chest Med. 2023; 44(1):95-103.

PMID: 36774172 PMC: 10148231. DOI: 10.1016/j.ccm.2022.10.008.


IL-1β-dependent extravasation of preexisting lung-restricted autoantibodies during lung transplantation activates complement and mediates primary graft dysfunction.

Yang W, Cerier E, Nunez-Santana F, Wu Q, Yan Y, Kurihara C J Clin Invest. 2022; 132(20).

PMID: 36250462 PMC: 9566897. DOI: 10.1172/JCI157975.


Clinical relevance of lung-restricted antibodies in lung transplantation.

Akbarpour M, Wu Q, Liu X, Sun H, Lecuona E, Tomic R Hum Immunol. 2019; 80(8):595-601.

PMID: 31078336 PMC: 6844365. DOI: 10.1016/j.humimm.2019.04.016.


Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.

Gauthier J, Ruiz-Perez D, Li W, Hachem R, Puri V, Gelman A Transplantation. 2018; 102(9):1459-1466.

PMID: 29683998 PMC: 6884147. DOI: 10.1097/TP.0000000000002250.


References
1.
Iwata T, Philipovskiy A, Fisher A, Presson Jr R, Chiyo M, Lee J . Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol. 2008; 181(8):5738-47. PMC: 2997998. DOI: 10.4049/jimmunol.181.8.5738. View

2.
Christie J, Kotloff R, Ahya V, Tino G, Pochettino A, Gaughan C . The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med. 2005; 171(11):1312-6. PMC: 2718464. DOI: 10.1164/rccm.200409-1243OC. View

3.
Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R . Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136(7):2348-57. View

4.
Vanaudenaerde B, De Vleeschauwer S, Vos R, Meyts I, Bullens D, Reynders V . The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant. 2008; 8(9):1911-20. DOI: 10.1111/j.1600-6143.2008.02321.x. View

5.
Shilling R, Wilkes D . Role of Th17 cells and IL-17 in lung transplant rejection. Semin Immunopathol. 2011; 33(2):129-34. PMC: 3945469. DOI: 10.1007/s00281-011-0257-9. View